Gene · 6624
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanistic insights into inflammatory cytokines in adenomyosis‑induced infertility (Review). | Int J Mol Med | 2026 | 41789648 | PubTator, text mining | PubMed |
| Takotsubo Syndrome: The First Non-Acute Proteomic Analysis by Remote Dried Blood Microsampling. | J Cardiovasc Transl Res | 2026 | 41760974 | PubTator, text mining | PubMed |
| Are self-management skills associated with depressive symptoms, quality of life, and healthcare utilisation? A cross-sectional survey among patients with advanced cancer in the Netherlands. | BMJ Open | 2026 | 41760151 | PubTator, text mining | PubMed |
| The Role of Actin-Binding Proteins in Breast Cancer Progression. | Breast Cancer (Dove Med Press) | 2026 | 41743193 | PubTator, text mining | PubMed |
| Morphological innovation without gene co-option: the Drosophila sex comb evolved via changes in developmental tempo and energy metabolism. | bioRxiv | 2026 | 41727116 | PubTator, text mining | PubMed |
| The Role of PDE3A in Cancer. | ACS Omega | 2026 | 41726589 | PubTator, text mining | PubMed |
| Multiple opportunistic infections revealing Erdheim-Chester disease: an atypical presentation. | BMJ Case Rep | 2026 | 41713886 | PubTator, text mining | PubMed |
| Polystyrene nanoplastics disrupt ovarian development via cytoskeletal remodeling and epigenetic reprogramming particularly in granulosa cells. | J Hazard Mater | 2026 | 41707395 | PubTator, text mining | PubMed |
| Mapping metastatic potential through cytoskeletal remodeling: A mechanobiology-based multi-cancer analysis. | Biochem Biophys Res Commun | 2026 | 41707378 | PubTator, text mining | PubMed |
| Fascin expression is associated with aggressive clinicopathological features in parathyroid tumors. | Hum Pathol | 2026 | 41687791 | PubTator, text mining | PubMed |
| The Relationship between SALL4 and Fascin Expression and the Progression of Colorectal Carcinoma. | Asian Pac J Cancer Prev | 2026 | 41660921 | PubTator, text mining | PubMed |
| Mesothelial cells promote peritoneal invasion and metastasis of ascites-derived ovarian cancer cells through spheroid formation. | Sci Adv | 2026 | 41650261 | PubTator, text mining | PubMed |
| The moonlighting functions of glycolytic enzymes in tumorigenesis. | Cell Oncol (Dordr) | 2026 | 41627634 | PubTator, text mining | PubMed |
| Comprehensive profiling of Aβ40 and Aβ42 fibril-interacting proteins reveals PRKCG as a drug-targetable regulator of amyloidogenesis in Alzheimer's disease. | Alzheimers Dement | 2026 | 41572619 | PubTator, text mining | PubMed |
| CAR-T triggers TAM reeducation and adaptive anti-tumor response via TREM2 deficiency or CD40 agonist. | Cell Rep Med | 2026 | 41564864 | PubTator, text mining | PubMed |
| Fertility-sparing surgery with neoadjuvant chemotherapy in early and locally advanced cervical cancer: A clinical protocol. | PLoS One | 2026 | 41529018 | PubTator, text mining | PubMed |
| Low YTHDC1 Expression Upregulates FSCN1 to Promote Nuclear F-Actin Formation and Facilitate Double-strand DNA Breaks Repair in TMZ-Resistant Glioblastoma. | Adv Sci (Weinh) | 2026 | 41454694 | PubTator, text mining | PubMed |
| Beyond Catalytic Therapy: Copper-Paeonol Nanozymes Disrupt Fascin-Mediated Actin Bundling to Suppress Tumor Growth and Metastasis. | Adv Sci (Weinh) | 2026 | 41405370 | PubTator, text mining | PubMed |
| Deciphering the role of angiogenesis in glioblastoma: Integrative insights from transcriptomic profiling, single-cell sequencing and interpretable machine learning approaches. | Pathol Res Pract | 2026 | 41380386 | PubTator, text mining | PubMed |
| Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer. | Prostate Cancer Prostatic Dis | 2026 | 41366132 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6624/papers?page=2